HIGGINS GENERAL HOSPITAL
1. Target Overview & Investment Thesis
HIGGINS GENERAL HOSPITAL is a 23-bed suburban community hospital in HARALSON, GA with $41.2M in net patient revenue and a 21.2% operating margin. The hospital serves a payer mix of 37.2% Medicare, 1.3% Medicaid, and 61.5% commercial.
Thesis: Turnaround. Our ML models identify $3.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 21.2% to 28.5% (+736bps).
| Net Revenue HCRIS | $41.2M |
| Current EBITDA COMPUTED | $8.7M |
| Operating Margin COMPUTED | 21.2% |
| Occupancy HCRIS | 53.1% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 31.3% |
| Distress Probability ML | 46.1% |
2. Market Context & Competitive Position
GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of 21.2% places it above the state median. Among 53 size-comparable peers (12-46 beds), the median margin is -5.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-46), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HIGGINS GENERAL HOSPITAL (Target) | GA | 23 | $41.2M | 21.2% |
| UNION GENERAL HOSPITAL | GA | 39 | $108.6M | 2.4% |
| TATTNALL HOSPITAL COMPANY LLC | GA | 25 | $101.7M | 41.9% |
| MILLER COUNTY HOSPITAL | GA | 25 | $81.6M | -1.1% |
| BURKE MEDICAL CENTER | GA | 40 | $55.7M | 34.7% |
| SGHS - CAMDEN CAMPUS | GA | 40 | $54.9M | -10.3% |
| EFFINGHAM HOSPITAL | GA | 25 | $53.8M | -39.8% |
| STEPHENS COUNTY HOSPITAL | GA | 40 | $49.4M | 6.0% |
| LIBERTY REGIONAL MEDICAL CENTE | GA | 25 | $46.0M | -14.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $866K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $825K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $817K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $502K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $26K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $8.7M |
| + RCM Uplift | +$3.0M |
| Pro Forma EBITDA | $11.8M |
| Current Margin | 21.2% |
| Pro Forma Margin | 28.5% |
| WC Released (1x) | $1.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $13.4M | $88.0M | 6.55x | 45.6% |
| Base (11x exit) | 10.0x | 11.0x | $13.4M | $101.1M | 7.53x | 49.7% |
| Bull Case | 9.0x | 11.0x | $12.1M | $115.5M | 9.55x | 57.0% |
| Bull (12x exit) | 9.0x | 12.0x | $12.1M | $129.6M | 10.71x | 60.7% |
| Bear Case | 11.0x | 10.0x | $14.8M | $68.4M | 4.63x | 35.9% |
| Bear (11x exit) | 11.0x | 11.0x | $14.8M | $80.1M | 5.42x | 40.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 12-46 beds
- Same-state prioritization (n=54)
- Comp margins: P25=-18.3% / P50=-5.0% / P75=3.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.